Opinion
Video
Author(s):
Coming into CHEST 2024, Steven Nathan, MD, discusses how the largest unmet needs in the treatment and management of IPF and PAH include improving early diagnosis, addressing symptom management (particularly chronic cough), and developing more effective, accessible therapies to enhance long-term patient outcomes.
1. Coming into CHEST 2024, what would you consider to be the largest unmet needs in the treatment and management of IPF and PAH?